Intriguing Movement in the Shareholdings of Advanced Medical Solutions: Unpacking the Changes on the Board

Advanced Medical Solutions Group plc, a leading name in tissue-healing technologies, is experiencing a dramatic change as multiple directors and Persons Discharging Managerial Responsibilities (PDMRs) shuffle their shareholdings. At the centre of this adjustment is the company’s Share Incentive Plan (SIP) and Employee Share Purchase Plan (ESPP) - schemes that allow employees and directors to reinvest part of their salary or bonus into company shares, earning matching shares deferred for at least three years.

Susan Searle, a Non-Executive Director, and her husband Fraser Searle both acquired 5,000 ordinary shares, strengthening their position in the company. At the same time, CEO Chris Meredith and CFO Eddie Johnson have made strategic moves, selling existing shares to reinvest in the company via the SIP and ESPP.

Meredith, executed the exercise of 64,000 nil-cost options from the existing Long Term Incentive Plan (LTIP), selling the resultant ordinary shares to purchase shares under the SIP and ESPP. Similarly, CFO Eddie Johnson exercised 28,126 nil-cost options from the LTIP, selling the resultant ordinary shares to also fund share acquisition under the SIP and ESPP programs.

In addition, Meredith and Johnson exercised outstanding nil-cost LTIPs and nil-cost ESPP matching shares to transfer into their own names, selling a portion of these to cover tax and National Insurance. These shifts are indicative of a dedicated investment in the ongoing health and profitability of the company from the top, setting an example of belief in the firm’s future.